-
Most Recent
Cannabis Stocks
Cannabis is a psychoactive drug that is a part of the Cannabacaee plant family. In the past few years, acceptance of the drug has risen dramatically. Industry leaders, like Canopy Growth and Curaleaf, are quickly establishing the framework for legal cannabis sales. THC is believed to be the component in cannabis that creates the psychoactive effect, which can be used to treat depression, anxiety, sleeping problems, and a wide range of other issues.
3 Cannabis Stocks That Can Be Massive Wealth Creators by 2030
These are the cannabis stocks to buy as they represent companies with improving fundamentals and accelerated growth outlook.
7 Growth Stocks That Could 7X in the Next 7 Years
Investors consider these growth stocks to buy since they represent companies with good fundamentals and a positive industry outlook.
3 Cannabis Stocks to Sell in August Before They Crash & Burn
Marijuana could be a major industry in the U.S. if it was legalized but these cannabis stocks to sell have other problems to contend with.
Other industries you might be interested in
Recent Cannabis Stocks Articles
It Doesn’t Look as If the ACB Stock Turnaround Is Coming Any Time Soon
After struggling in 2019, investors are hoping for a fresh start for Aurora stock. Here are a few things you need to know about ACB stock.
Canopy Growth Stock Looks Ready to Gain From Big Catalysts in 2020
Canopy Growth stock investors are excited about a new CEO at the helm and new Cannabis 2.0 products on the way. CGC stock looks primed for 2020.
Hexo Stock Is in a Race Against Time
Hexo stock has fallen just over 80% as it waits for Cannabis 2.0 to take root. However, after a year of overpromising, investors' patience is thin.
What Hexo Stock Needs Is Some Old-Fashioned Reaganomics
Last year was a year of reckoning for Hexo stock and the broader cannabis market. However, most of the pain may have resulted from unnecessary government inefficiencies.
Thursday’s Vital Data: Bristol-Myers Squibb, Cronos and Canopy Growth
Options trading was hot in Bristol-Myers Squibb, Cronos and Canopy Growth stock on Tuesday. Here’s what the data suggests moving forward.
Aurora Stock Will Have Another Rough Year
The shaky financials of Aurora stock make ACB stock one of the worst choices in the marijuana industry.
There’s No World Where ACB Stock Plummets to Nothing
One analyst recently made a bold prediction that ACB stock is completely worthless. While Aurora remains an extremely risky bet, the stock will never make it to $0.
Is Canopy Growth a Worthy Investment in 2020?
Canopy Growth has been hammered in 2019, along with the the rest of the cannabis space. Is a rebound ready to go?
Here’s Why You Should Pay More, Not Less for Aphria Stock
Aphria stock is already delivering on the bottom line for its shareholders. It's also shaping up to deliver big profits in 2020.
Avoid Aurora Cannabis As Shares Have No Fight Left
The cannabis space is struggling, and making investments in this area is speculative. With that said, Aurora Cannabis acts too bad to touch.
Can Canopy Growth Rise Above the Cannabis Industry’s Reputation?
The cannabis industry suffered horribly in 2019 and Aurora Cannabis’ controversial executive departure creates a trust issue for Canopy Growth and other major players.
U.S. Cannabis Stocks Will Make Cheap, Smart Buys in 2020
Matt McCall predicts that 2020 will be a better year for U.S. cannabis stocks. He's also calling for a big rally in bitcoin.
Is Aphria the Best Cannabis Stock to Buy?
Aphria stock has some of the best financials in the cannabis space, but that hasn't stopped APHA stock from getting hit like its peers.
Why Aurora Cannabis Should See a Turn for the Better in 2020
Aurora is ending the year on a sour note, but could be setting up for a much better 2020. Here’s a look at three key factors for the bull case.
Make Aurora Cannabis Front and Center in Your Pot-folio
Ignore the haters. Aurora Cannabis isn't headed to zero anytime soon. In fact it might just become the cannabis market's hero in 2020.
Canopy Growth Could Surprise in 2020, but Don’t Rush In
With strong capitalization, Canopy Growth is a "safer" pot stock play. But to tilt the odds in your favor, take your time before buying.
Hexo Hoping to Recover With Cannabis 2.0 Boom in 2020
With Cannabis 2.0 in the works, Hexo’s risk-reward profile is beginning to look very favorable for investors willing to stick their necks out. Here’s why.
Aurora Stock Dove After an Analyst Gave It a $0 Price Target
Aurora stock took another hit on Monday after a research analyst set a $0 price target on ACB stock, citing high debt and high supply.
